© 2025 Incunabulum LLC. All rights reserved. mg Magazine is a registered trademark of Incunabulum LLC. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Incunabulum LLC.
Matthew Myro Rothman
Matthew Myro Rothman is a marketer, cultivator, and educator with two decades at the intersection of cannabis science and patient access. As chief science officer and vice president of marketing at EM2P2, he guides national strategy and consumer education initiatives for CannaLnx, a digital health platform devoted to modernizing healthcare by integrating the power of medical cannabis into traditional care models and systems. A Cleveland native with a master’s degree from the California Institute of Integral Studies, Rothman hosted the Edge of Cannabis Medicine podcast, where he interviewed researchers and innovators shaping the role of cannabis in health care. He is also a certified yoga, tai chi and qigong instructor, a personal trainer, and a longtime singer-songwriter.
The Next Prescription for Growth
Federal rescheduling may give cannabis operators more than tax relief and investor confidence. The next real growth opportunity lies in building medical cannabis into healthcare infrastructure: provider visibility, compliant data systems, patient records, eligibility verification, education, and reimbursement pathways. Retail discipline helped the industry mature, but healthcare legitimacy will require operators to support patients, not just sell products.